Mesa Laboratories, Inc. MLAB

134.04 (3.46) (2.52%) as of 25 Sep
Market cap
$769.4M
P/E
156×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Cash and Short Term Investments
26.93 27.32 28.21 32.91 49.35 263.87 81.38 10.19 5.47 5.82
Receivables
44.10 41.97 39.06 42.55 41.22 23.79 21.13 12.52 14.30 14.32
Inventory
26.37 25.37 32.68 34.64 24.61 11.18 14.23 6.77 9.23 13.87
Other current assets
79.34 — 81.14 8.87 9.14 4.92 6.05 3.94 1.93 1.77
Total current assets
106.27 102.69 109.35 118.98 124.32 303.75 122.79 33.62 31.99 35.79
Property, Plant, Equpment (Net)
30.61 32.33 31.77 28.15 28.62 22.00 22.07 22.23 23.59 26.00
Goodwill and Intangible Assets (Total)
270.21 278.64 293.85 503.26 541.28 272.58 261.41 99.60 108.39 109.95
Long Term Assets (Tax, Deferred)
1.50 1.37 1.29 1.08 1.32 0.62 0.36 1.32 0.13 —
Long-term assets (Other)
19.16 18.32 10.54 10.37 11.83 2.53 2.48 0.21 — —
Total non-current assets
321.48 330.66 337.44 542.86 583.05 297.73 286.32 123.14 132.11 135.95
Total Assets
427.75 433.35 446.80 661.83 707.37 601.48 409.11 156.77 164.10 171.73
Notes Payable
— 97.30 — — — — — 2.13 1.63 1.13
Accounts Payable
4.93 5.75 6.04 6.13 7.90 4.47 3.41 2.90 2.38 2.17
Accrued Expenses
19.01 17.86 9.94 9.43 14.72 9.39 8.94 7.32 4.28 4.35
Current Part of Debt
5.63 3.75 — 2.87 2.77 1.02 1.10 2.13 1.63 1.13
Current Part of Taxes to Pay
— — — — — 1.65 0.24 — 1.01 0.51
Other current liabilities
14.72 14.71 15.48 15.69 13.83 8.78 6.81 7.31 4.63 5.41
Total current liabilities
61.90 163.96 44.31 43.36 48.06 32.58 26.01 23.66 17.29 16.57
Long Term Debt (Total)
145.86 76.90 221.70 183.27 218.37 145.68 140.28 20.61 44.64 53.68
Long Term Tax Liability (Deferred)
20.09 20.18 19.78 34.03 39.22 16.28 21.45 1.08 2.62 3.55
Non-current Liabilities (Other)
13.66 12.47 15.61 7.69 7.92 0.72 1.36 0.11 0.19 0.12
Total non-current liabilities
179.60 109.56 257.09 224.99 265.51 162.67 163.09 21.80 47.45 57.35
Total liabilities
241.50 273.52 301.40 268.35 313.57 195.25 189.10 45.46 64.74 73.91
Common Stock (Net)
375.35 358.54 343.64 332.08 313.46 317.65 158.02 39.82 30.52 25.93
Retained Earnings
(185.75) (188.94) (183.49) 74.20 76.68 72.46 72.36 73.30 68.28 73.66
Common Equity (Total)
186.25 159.83 145.39 393.48 393.80 406.23 220.01 111.31 99.36 97.82
Shareholders Equity (Total)
186.25 159.83 145.39 393.48 393.80 406.23 220.01 111.31 99.36 97.82
Shareholders Equity and Liabilities (Total)
427.75 433.35 446.80 661.83 707.37 601.48 409.11 156.77 164.10 171.73
Shares (Common)
5.53 5.46 5.39 5.37 5.27 5.14 4.39 3.89 3.80 3.73
Shareholders Equity (Tangible)
(83.96) (118.80) (148.45) (109.78) (147.48) 133.65 (41.39) 11.72 (9.03) (12.12)
Net Debt
124.55 53.33 193.48 153.23 171.79 (117.17) 59.99 12.55 40.79 48.98
Total Debt
151.48 80.65 221.70 186.14 221.13 146.70 141.37 22.74 46.26 54.80

Fold the line items

In millions of $ except per-share values · columns are period end dates